8-K: Select Medical 2026 Annual Meeting Results

Select Medical Holdings Corporation stockholders approved all management proposals at the 2026 Annual Meeting, including a board declassification amendment.

Summary

• The 2026 Annual Meeting of Stockholders was held on April 23, 2026.
• Stockholders elected three Class II directors: Robert A. Ortenzio, Daniel J. Thomas, and Parvinderjit S. Khanuja.
• The appointment of PricewaterhouseCoopers LLP as the independent auditor for 2026 was ratified.
• Stockholders approved an amendment to phase out the classified board structure.
• A management proposal to allow stockholders to call special meetings at a 25% ownership threshold was approved.
• A competing shareholder proposal to lower the special meeting threshold to 10% was rejected.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral, routine governance update that reflects standard corporate housekeeping and successful management of shareholder voting.

Positives

• High level of shareholder support for the election of all nominated directors.
• Successful ratification of the independent auditor.
• Approval of corporate governance improvements, specifically the declassification of the board.

Negatives

• Significant opposition to the 25% ownership threshold for calling special meetings, with over 13.3 million votes against and 4.2 million abstentions.

Risks

• Potential for continued shareholder activism regarding the special meeting ownership threshold, given the rejection of the 10% proposal.

Future Outlook

The company will proceed with the declassification of the board and implement the 25% ownership threshold for special meetings as approved by shareholders.

Industry Context

StockSavvy.ai notes that the move to declassify the board is consistent with broader institutional investor trends favoring increased board accountability and annual director elections.

Comparison to Industry Standards

• The transition to a declassified board structure aligns Select Medical with S&P 500 best practices for corporate governance.
• The 25% threshold for calling special meetings is a common standard among mid-cap healthcare companies, though some activists continue to push for 10%.

Corporate Governance

Stakeholder Impact

• Shareholders gain increased influence through the declassification of the board.
• Management maintains control over the special meeting process by successfully defeating the 10% threshold proposal.

Next Steps

• Implementation of the certificate of incorporation amendment to phase out the classified board structure.
• Formal engagement of PricewaterhouseCoopers LLP for the 2026 fiscal year audit.

Key Dates

Keywords

Select Medical, Annual Meeting, Corporate Governance, Board Declassification, Proxy Voting, SEM